Product Information

TADALAFIL 5 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.1134 per EA under NDC 82009007705. Its NADAC has been published 162 times since Oct 18, 2023.

FDA first approved this application on Mar 26, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TADALAFIL 5 MG TABLET

Tadalafil
$0.1134per EA

Strength

5 mg/1

NDC

82009007705

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TADALAFIL

Approval Type

Generic (ANDA)

FDA Application

ANDA209654

FDA Approved

3/26/2019

TE Code

AB1

On Market Since

7/19/2023

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price Statistics

The NADAC for TADALAFIL 5 MG TABLET has been published 162 times since Oct 18, 2023, and over the history we have for it it has declined 25.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1134 per EA
All-time high$0.2329 (Feb 14, 2024)
All-time low$0.0842 (Nov 20, 2024)
52-week high$0.1162
52-week low$0.1014
Median price$0.1126
Average price$0.1232
Largest weekly change+47.6% (Aug 21, 2024)
Weeks tracked162
Tracking sinceOct 18, 2023

Price History

1W

+5.3%

1M

+9.9%

3M

+11.0%

6M

+7.8%

1Y

-2.4%

3Y

-25.2%

5Y

N/A

All

-25.2%

Generic Alternatives

The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TADALAFIL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 5 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.1134 per EA (NDC 82009007705), effective Nov 18, 2026.

How has the price of TADALAFIL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for TADALAFIL 5 MG TABLET has declined 25.2%. It has been tracked across 162 weekly CMS publications since Oct 18, 2023.

What are the highest and lowest recorded NADAC prices for TADALAFIL 5 MG TABLET?

Since Oct 18, 2023, the NADAC for TADALAFIL 5 MG TABLET has ranged from a low of $0.0842 (Nov 20, 2024) to a high of $0.2329 (Feb 14, 2024), with a median of $0.1126 per EA.

Are there cheaper alternatives to TADALAFIL 5 MG TABLET?

Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TADALAFIL 5 MG TABLET, is $0.1043 per EA — about 8% below TADALAFIL 5 MG TABLET.

Who manufactures TADALAFIL 5 MG TABLET?

TADALAFIL 5 MG TABLET (NDC 82009007705) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.